Hu Xiaoxiao, Li Yang, Ma Hongwen, Xiong Lina, Tan Jiping, Jin Yanfei
School of Nursing, Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing, 211166, Jiangsu, China.
Department of nursing, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, 300121, Tianjin, China.
Health Qual Life Outcomes. 2025 Apr 15;23(1):39. doi: 10.1186/s12955-025-02368-w.
Health behavior plays a major role in the development, progression, and prognosis of cancer. The Health Behavior Scale for Cancer Patients (HBSCP) can be used to assess the level of health behavior in cancer patients. This study aimed to explore its psychometric properties and Measurement Invariance (MI) in the Chinese cancer population.
A longitudinal study was conducted with 567 cancer patients across two hospitals, and 428 participants underwent a second assessment three months later. Analyses were performed to evaluate reliability (internal consistency), validity (structural validity, convergent validity, and criterion-related validity), and MI of the Chinese version of the HBSCP.
The two-factor structural model of the 9-item scale demonstrated an excellent fit in Confirmatory Factor Analysis (CFA). Psychometric analyses indicated strong internal consistency, with Cronbach's alpha coefficients ranging from 0.846 to 0.899 and McDonald's Omega values between 0.847 and 0.897. Convergent validity was supported by Composite Reliability (CR > 0.70) and Average Variance Extracted (AVE > 0.50). Criterion-related validity was established via significant correlations with the Health-Promoting Lifestyle Profile II (HPLP-II; r = 0.653 ~ 0.760). Multi-group CFA further confirmed MI across cancer types (ΔCFI&TLI < 0.01; ΔRMSEA < 0.015) and time groups (3-month interval).
This study provides longitudinal evidence supporting the adequate psychometric properties and temporal stability of the Chinese version of the HBSCP, thus validating its utility for measuring health behavior in Chinese cancer populations. The Chinese HBSCP can serve as a tool for healthcare providers to assess the current status and changes in health behavior among cancer patients.
健康行为在癌症的发生、发展和预后中起着重要作用。癌症患者健康行为量表（HBSCP）可用于评估癌症患者的健康行为水平。本研究旨在探讨其在中国癌症人群中的心理测量学特性和测量不变性（MI）。
对两家医院的567名癌症患者进行了一项纵向研究，428名参与者在三个月后接受了第二次评估。进行分析以评估中文版HBSCP的信度（内部一致性）、效度（结构效度、收敛效度和效标关联效度）和MI。
9项量表的双因素结构模型在验证性因子分析（CFA）中显示出良好的拟合。心理测量学分析表明内部一致性很强，克朗巴哈α系数在0.846至0.899之间，麦克唐纳ω值在0.847至0.897之间。复合信度（CR＞0.70）和平均提取方差（AVE＞0.50）支持收敛效度。通过与健康促进生活方式量表II（HPLP-II；r = 0.653～0.760）的显著相关性建立了效标关联效度。多组CFA进一步证实了跨癌症类型（ΔCFI&TLI＜0.01；ΔRMSEA＜0.015）和时间组（3个月间隔）的MI。
本研究提供了纵向证据，支持中文版HBSCP具有足够的心理测量学特性和时间稳定性，从而验证了其在中国癌症人群中测量健康行为的效用。中文版HBSCP可作为医疗保健提供者评估癌症患者健康行为现状和变化的工具。
